CD59 and pancreatic neoplasm: To dissect the function of CD59 in pancreatic cancer cells against CDC, we used siRNAs to inhibit CD59 expression in AsPC-1 and BxPC-3, which was detected by western blot and FCM (Fig. 4d, e).